• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Fidelity Digital Health ETF
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BlossomHill Therapeutics, Inc. - Common Stock (NQ:BLSM)

13.94 -1.04 (-6.94%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 293,112
Open 14.79
Bid (Size) 14.21 (100)
Ask (Size) 20.98 (600)
Prev. Close 14.98
Today's Range 13.31 - 14.79
52wk Range 13.31 - 27.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
September 28, 2026
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire
News headline image
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
September 18, 2026
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 50.2% below 52-week high
13.94
13.3152W Low 27.9952W High
1 Week 23.5% below 1-week high
13.311W Low 18.211W High

BlossomHill Therapeutics, Inc. - Common Stock (BLSM) traded between $13.31 and $27.99 over the past 52 weeks and last traded at $13.94, 50.2% below its 52-week high. Over the past week it ranged between $13.31 and $18.21.

Past 12 Months
-19.3%
-48.0%
-12.9%
-12.9%
-12.9%
-12.9%
1W -$3.33
1M -$12.88
3M -$2.06
6M -$2.06
YTD -$2.06
1Y -$2.06

BLSM was -12.9% over the past year, -12.9% over six months, -12.9% year to date, -19.3% in the last week.

12 Months vs Market
BLSM
-12.9%
DIA
+12.4%
SPY
+14.9%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months BLSM returned -12.9% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 1.17× 3-mo avg
Today 293,112 3-mo avg 249.5K
1W
169.9K
1M
231.6K
3M
249.5K
6M
249.5K
YTD
249.5K
1Y
249.5K

BLSM most recently traded 293,112 shares against a 3-month average daily volume of 249.5K.

More News

Read More
News headline image
BlossomHill Therapeutics Presents Updated Data from Ongoing Phase 1/2 SOLARA Trial Demonstrating Encouraging Anti-Tumor Activity of OMNI-EGFR™ Inhibitor BH-30643 in EGFR C797S-Positive NSCLC at IASLC 2026 World Conference on Lung Cancer
September 15, 2026
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire
News headline image
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
September 03, 2026
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire
News headline image
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer
September 01, 2026
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire
News headline image
Insiders Are Betting Big on These 3 Healthcare Stocks ↗
August 31, 2026
Via MarketBeat
Topics Initial Public Offering
News headline image
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
August 18, 2026
From BlossomHill Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is BlossomHill Therapeutics, Inc. - Common Stock publicly traded?
Yes, BlossomHill Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BlossomHill Therapeutics, Inc. - Common Stock trade on?
BlossomHill Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BlossomHill Therapeutics, Inc. - Common Stock?
The ticker symbol for BlossomHill Therapeutics, Inc. - Common Stock is BLSM on the Nasdaq Stock Market
What is the current price of BlossomHill Therapeutics, Inc. - Common Stock?
The current price of BlossomHill Therapeutics, Inc. - Common Stock is 13.94
When was BlossomHill Therapeutics, Inc. - Common Stock last traded?
The last trade of BlossomHill Therapeutics, Inc. - Common Stock was at 10/16/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap